Denis Corin, President and CEO of Q BioMed Inc. (OTCQB: QBIO) Talks to Daniel Levine of the Bio Report
Pharma Bro, Price Controls, and the Quest to Balance Innovation with Affordability; Perspective on the fallout from Shkreli
March 2, 2016 - Investorideas.com a global digital media source covering leading sectors including biotech stocks profiles the following biotech interview. ... Read more